Ayaka Tsuge
Overview
Explore the profile of Ayaka Tsuge including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
374
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tsuge A, Watanabe S, Kawazoe A, Togashi Y, Itahashi K, Masuda M, et al.
Cancer Immunol Res
. 2024 Nov;
13(2):273-285.
PMID: 39602577
Regulatory T (Treg) cells play key roles in cancer immunity by suppressing a range of antitumor immune responses and contributing to resistance to PD-1 blockade therapy. Given their critical roles...
2.
Kumagai S, Togashi Y, Kamada T, Sugiyama E, Nishinakamura H, Takeuchi Y, et al.
Nat Immunol
. 2020 Sep;
21(11):1346-1358.
PMID: 32868929
Immune checkpoint blockade has provided a paradigm shift in cancer therapy, but the success of this approach is very variable; therefore, biomarkers predictive of clinical efficacy are urgently required. Here,...
3.
Itoh T, Muramatsu Y, Masu M, Tsuge A, Taniguchi M, Ninomiya M, et al.
Nutr Cancer
. 2014 Oct;
66(8):1414-23.
PMID: 25333640
Nostocionone (Nost), a compound isolated from Nostoc commune, and its synthesized derivatives (NostDs) were evaluated for in vitro cytotoxicity against human T-cell leukemia Jurkat cells. NostD3 [(1E,4E)-1-(3,4-dihydroxyphenyl)-5-(2,6,6-trimethylcyclohex-1-enyl)penta-1,4-dien-3-one] inhibited cell growth...